Senior doctor admits 'doubting his own judgement' after a teenage girl died from sepsis - but tells tribunal he did not make any wrong decisions
A senior doctor said he 'doubted my own judgment' after a teenage girl died from sepsis - but told a medical tribunal he did not believe he made any wrong decisions.
Professor Richard Thompson is accused of numerous failings in his treatment of Martha Mills, 13, at London 's King's College Hospital two days before she died in August 2021.
More than a month earlier Martha had suffered an injury to her pancreas after she fell off a bike while on holiday in Wales.
She was later transferred to King's College Hospital, one of three locations in the UK that specialise in the treatment of children with pancreatic injuries.
The consultant hepatologist saw Martha on a morning ward round on Sunday, August 29, after she experienced fevers and an increased heart rate in the days prior.
She was given intravenous fluids that day as her blood pressure was low, a Medical Practitioners Tribunal Service (MPTS) panel heard.
Professor Thompson said: 'She was very much awake and interacting, she was having the fluid. She was clearly not well but she was warm, well perfused, talking and making complete sense.'
The fluids were increased from late afternoon when the blood pressure reading was still low.
The duty registrar called Professor Thompson at home when Martha developed a rash.
Professor Thompson said: 'He gave a description of a rash in many places... it was very suggestive of an allergic rash and not a septic rash. I had no reason to disbelieve his description.'
He said the registrar was 'at the most experienced end of a junior doctor that you could have' as he was completing his final months of training.
Professor Thompson said he could not recall the figures from blood pressure and blood test readings that were relayed to him before he phoned a consultant colleague to consider whether Martha should be moved to intensive care.
The General Medical Council (GMC) says Professor Thompson gave 'outdated' information about those readings which gave the false impression that Martha was stable, and that he also failed to mention her rash.
The GMC also says he should have returned to the hospital to review Martha himself after he was informed about the rash and should have acted sooner in recommending a critical care review.
Martha collapsed the next morning and was moved to intensive care before she was transferred to Great Ormond Street Hospital, where she died in the early hours of August 31.
After her death, Professor Thompson decided he would no longer provide inpatient care as he became 'extremely cautious', the tribunal heard.
He said: 'I was doubting my own judgment. I don't believe I made any wrong decisions but I thought it better to remove myself from that environment and contribute to other work in the department.'
His barrister Ben Rich asked: 'Did you ever doubt your judgment in Martha's case?'
He replied: 'Absolutely. I think I was on record saying that I felt I made a mistake and other times I said I didn't.'
Professor Thompson denies all the allegations against him.
The hearing in Manchester continues.
At a 2022 inquest into her death, a coroner ruled Martha would most likely have survived if doctors had identified the warning signs and transferred her to intensive care earlier.
Martha's mother, Merope Mills, an editor at The Guardian, said she and her husband, Paul Laity, raised concerns about Martha's deteriorating health a number of times but these were not acted on.
The couple later successfully campaigned for Martha's Rule to give patients, families and carers the chance to easily request a second opinion from a senior doctor in the same hospital in the event of a suspected deterioration or serious concern.
Earlier this year the House of Commons Health and Social Care Committee was told that more than 100 patients had been taken to intensive care 'or equivalent' as a result of Martha's Rule, and that patients, their loved ones or staff had raised concerns about care using the rule on more than 2,000 occasions.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
an hour ago
- The Guardian
Monash IVF chief executive resigns after company's second embryo transplant bungle
Monash IVF boss Michael Knaap has resigned in the wake of the reproductive healthcare company's second embryo transplant bungle. In a statement to the ASX, Monash IVF said the board had accepted Knaap's resignation as chief executive officer and managing director. This week, Monash IVF admitted to a second bungled embryo implant. In April, Monash IVF revealed a woman had given birth to the child of an unrelated woman after a separate incorrect embryo transplant in Queensland. Monash IVF said in the statement on Thursday that it 'acknowledges and respects [Knaap's] decision'. 'Since his appointment in 2019, Michael has led the organisation through a period of significant growth and transformation, and we thank him for his years of dedicated service,' the statement said. Malik Jainudeen, Monash IVF chief financial officer and company secretary, will serve as acting chief executive. Experts are now calling for national regulation of the sector, something that the health minister, Mark Butler, said would be discussed on Friday when health ministers meet in Melbourne. Currently, IVF is regulated by state and territory laws, but a more consistent, federal approach is being urged. Clinics must be licensed by the Reproductive Technology Accreditation Committee (RTAC), a subcommittee of the Fertility Society of Australia and New Zealand (FSANZ). That's the unit that carries out audits, including on some assisted reproductive technology (ART) clinics internationally. Clinics must also follow ethical guidelines from the National Health and Medical Research Council. FSANZ said in a statement about the latest Monash IVF incident that Australia's fertility care system was 'among the safest, most transparent, and tightly regulated in the world'. FSANZ president Dr Petra Wale said errors were 'exceedingly rare' although 'deeply difficult for those affected'. FSANZ has called for a nationally consistent framework for ART, and an independent statutory authority to 'strengthen oversight and trust'. It said that while the clinical standards in IVF clinics are nationally consistent, each state and territory has its own legislation. Transitioning the RTAC to an independent statutory authority would strengthen the accreditation scheme with 'the regulatory clarity and operational flexibility needed to uphold rigorous standards and respond swiftly to emerging risks', it said, while a national approach to ART would 'strengthen transparency, streamline governance, and enhance patient care across the country'. The latest audit of Australian ART facilities found 172 non-conformance reports (NCRs), but only one was 'major'. Other countries audited, including New Zealand, had higher rates of NCRs. Professor Jeremy Thompson, from the University of Adelaide, is the cofounder and chief scientific officer at Fertilis Pty Ltd. Sign up to Afternoon Update Our Australian afternoon update breaks down the key stories of the day, telling you what's happening and why it matters after newsletter promotion He said there is a global shortage of well-trained and experienced embryologists, so 'levels of training and experience can vary', and that it was a stressful job where 'skill and time management are critical for the best outcome'. But he said that 'Australia's reputation as a leader in embryology training and technique auditing is beyond question'. University of NSW associate professor Kuldip Sidhu, co-founder and director of CK Cell Technologies, said more rigorous compliance was needed in the industry. Embryologists are not currently registered under a national scheme, and doing this would 'help in adding another layer of responsibility to check such mishappenings in the IVF industry', he said. Dr Evie Kendal, a senior lecturer in health promotion at Swinburne University of Technology, said that with more human intervention in reproduction there was an increased potential for human error. 'Previous safeguards are clearly not up to the challenge of protecting clients against such incidents, and urgent ethical and policy guidance is needed to prevent such mistakes from occurring again,' she said. On Tuesday, Monash IVF told the ASX it would extend the review into the Queensland incident and start a new investigation into the Victorian one. Victorian health minister, Mary-Anne Thomas, confirmed the Victorian health regulator was also investigating. She said Monash IVF's 'clinical governance standards are not where they should be'. Monash IVF said on Tuesday that as well as the investigations it would put extra verification processes and patient confirmation safeguards in place 'over and above normal practice and electronic witness systems, to ensure patients and clinicians have every confidence in its processes'.
The Independent
2 hours ago
- The Independent
Chancellor unveils £6bn NHS funding after health-centred spending review
Some £6 billion will be spent on speeding up testing and treatment in the NHS, Rachel Reeves has announced, after she placed the health service at the heart of Government spending plans. The Chancellor unveiled the investment, which includes new scanners, ambulances and urgent treatment centres aimed at providing an extra four million appointments in England over the next five years, after Wednesday's spending review. The funding is aimed at reducing waiting lists and reaching Labour's 'milestone' of ensuring the health service carries out 92% of routine operations within 18 weeks. In the review, Ms Reeves set out day-to-day spending across Government for the next three years, as well as plans for capital investment over the next four years. The NHS and defence were seen as the winners from the settlement, as both will see higher than average rises in public spending. This comes at cost of squeezing the budgets of other Whitehall departments and experts have warned tax rises may be needed later this year. The Chancellor and Sir Keir Starmer both sought to portray the review as a 'new phase' for the Government, following the criticism Labour has faced during its first year in power, including over cuts to winter fuel allowance. Ms Reeves claimed the NHS had been 'put on its knees' as a result of under-investment by the previous government, adding: 'We are investing in Britain's renewal, and we will turn that around.' The new £6 billion investment will come from the capital settlement for the NHS and will also help to speed up diagnoses with scans and treatment available in places such as shopping centres and high streets. The scale of day-to-day spending for the NHS is akin to an extra £29 billion a year. In a broadcast interview on Wednesday evening, Ms Reeves said the Government was 'confident' it could meet its pledge to reduce waiting lists after the boost to NHS spending. But while health and defence have benefited from the review, the Home Office, Ministry of Housing, Communities and Local Government, Department for Culture, Media and Sport, Department for Transport and Department for the Environment, Food and Rural Affairs are all in line for real-terms cuts in day-to-day spending. The Foreign Office is also in line for real-terms cuts, mainly as a result of a reduction in the overseas aid budget, which was slashed as part of the commitment to boost defence spending to 2.6% of gross domestic product – including the intelligence agencies – from 2027. Ms Reeves acknowledged 'not everyone has been able to get exactly what they want' following Cabinet squabbling over departmental budgets. She said 'every penny' of the spending increases had been funded through the tax and borrowing changes she had announced in her first budget. The Chancellor also insisted she would not need to mount another tax raid to pay for her plans, but experts warned the money for the NHS might still not be enough and the Government is under international pressure to boost defence funding further. Paul Johnson, of the Institute for Fiscal Studies, described the hospital waiting times target as 'enormously ambitious', adding: 'And on defence, it's entirely possible that an increase in the Nato spending target will mean that maintaining defence spending at 2.6% of GDP no longer cuts the mustard.' At a summit later this month Nato members will consider calls to increase spending to 3.5% on defence, with a future 1.5% on defence-related measures. Steven Millard, interim director of the NIESR economic research institute, said the Chancellor's non-negotiable fiscal rules, coupled with the 'small amount of headroom' in her spending plans, meant 'it is now almost inevitable that if she is to keep to her fiscal rules, she will have to raise taxes in the autumn budget'. Elsewhere, policing leaders warned forces may need to make deep cuts after their settlement was announced. The spending review provides more than £2 billion for forces, but ministers have acknowledged some of that 'spending power' will come from council tax hikes.
The Sun
3 hours ago
- The Sun
Addiction to ketamine rises eight-fold in a decade as powerful tranquiliser becomes popular with Gen Z
DOCTORS have sounded the alarm over an eight-fold rise in ketamine addiction in a decade. The powerful tranquilliser is popular with Generation Z because of its relatively low cost, experts say. Clinics in England treated 3,609 people of all ages for addiction last year, eight times more than 426 in 2014, figures reveal. Ketamine, also referred to as 'K' or 'Ket', numbs pain and can cause a trippy high. Dealers sell it in powder form for around £20 to £40 a gram compared with £40 to £60 a gram for low-quality cocaine. Doctors say heavy use can cause liver disease and permanently damage the bladder and kidneys. It is linked to constipation, depression and loss of mental sharpness. Many medics fail to understand how addictive it can be, an NHS report said. Led by Dr Irene Guerrini of the South London and Maudsley NHS Trust, it called the drug's prevalence 'concerning'. It said: 'As ketamine use increases, more individuals are seeking treatment for addiction. 'Long-term use can seriously harm both physical and mental health, diminishing quality of life, affecting personal relationships and impairing academic or professional performance.' Dr Guerrini called for stricter guidelines on how the NHS uses the drug and more funds for treatment and prevention. Ministers are considering uprating 34878330from a Class B to Class A drug.
